Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

reviewr.ai AG

History from 25 Aug 2021

UID
CHE-268.171.992
Legal form
AG
Canton
ZH
Founded
25 Aug 2021
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 135k
34k67k101k135k11 Nov 2022 · CHF 104k20 Feb 2025 · CHF 128k19 Sep 2025 · CHF 135k2023202420252026
  • shares
  • Vorzugsaktien Seed 1
  • Vorzugsaktien Seed 2a
  • Vorzugsaktien Seed 2b

Record

  1. Company formed

    Founded 25 Aug 2021

    SHAB HR01-1005279672 ↗
  2. Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    100’000 → 104’288.90
    Shares
    100’000 → 1’042’889
    New shares, % of post-step shares
    — (nominal value per share changed)

    Aktienkapital neu: CHF 104'288.90 [bisher: CHF 100'000.00]. Liberierung Aktienkapital neu: CHF 54'288.90 [bisher: CHF 50'000.00]. Aktien neu: 1'042'889 Namenaktien zu CHF 0.10 [bisher: 100'000 Namenaktien zu CHF 1.00].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1005602082 ↗
  3. Capital increase

    Not assessed

    Paid in cash and by other means

    Nominal capital
    104’288.90 → 127’969.30
    Shares
    1’042’889 → 1’279’693
    New shares, % of post-step shares
    18.5% (236’804 new)
    Share classes
    1’000’000 × CHF 0.10 · 54’176 × CHF 0.10 Vorzugsaktien Seed 1 · 12’929 × CHF 0.10 Vorzugsaktien Seed 2a · 212’588 × CHF 0.10 Vorzugsaktien Seed 2b

    Aktienkapital neu: CHF 127'969.30 [bisher: CHF 104'288.90]. Liberierung Aktienkapital neu: CHF 77'969.30 [bisher: CHF 54'288.90]. Aktien neu: 1'000'000 Namenaktien zu CHF 0.10, 54'176 Namenaktien zu CHF 0.10 (Vorzugsaktien Seed 1), 12'929 Namenaktien zu CHF 0.10 (Vorzugsaktien Seed 2a) und 212'588 Namenaktien zu CHF 0.10 (Vorzugsaktien Seed 2b) [bisher: 1'042'889 Namenaktien zu CHF 0.10].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1006262148 ↗
  4. Capital increase

    Likely financing

    Paid in cash

    Nominal capital
    127’969.30 → 134’768
    Shares
    1’279’693 → 1’347’680
    New shares, % of post-step shares
    5.0% (67’987 new)
    Share classes
    1’000’000 × CHF 0.10 · 54’176 × CHF 0.10 Vorzugsaktien Seed 1 · 12’929 × CHF 0.10 Vorzugsaktien Seed 2a · 280’575 × CHF 0.10 Vorzugsaktien Seed 2b

    Aktienkapital neu: CHF 134'768.00 [bisher: CHF 127'969.30]. Liberierung Aktienkapital neu: CHF 134'768.00 [bisher: CHF 77'969.30]. Aktien neu: 1'000'000 Namenaktien zu CHF 0.10, 54'176 Namenaktien zu CHF 0.10 (Vorzugsaktien Seed 1), 12'929 Namenaktien zu CHF 0.10 (Vorzugsaktien Seed 2a) und 280'575 Namenaktien zu CHF 0.10 (Vorzugsaktien Seed 2b) [bisher: 1'000'000 Namenaktien zu CHF 0.10, 12'929 Namenaktien zu CHF 0.10 (Vorzugsaktien Seed 2a), 54'176 Namenaktien zu CHF 0.10 (Vorzugsaktien Seed 1) und 212'588 Namenaktien zu CHF 0.10 (Vorzugsaktien Seed 2b)].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.80 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006437127 ↗

Published by 8 Oct 2026